Sarah Otten Joins Medison Pharma as VP, GM Americas Region
Sarah Otten will lead Medison's Americas region covering Canada and Latin America. Sarah brings vast geographical expansion experience in international markets. PETACH TIKVAH, Israel and ZUG, Switzerland, Jan. 9, 2023 /PRNewswire/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets...
Dizal Announces China CDE Acceptance of New Drug Application for Sunvozertinib for Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations
SHANGHAI, Jan. 10, 2023 /PRNewswire/ -- Dizal (SHEX: 688192) today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for sunvozertinib for the treatment of advanced NSCLC with EGFR exon20ins mutations after platinum-based chemotherapies. Sunvozertinib (DZD9008) is an investigational, best-in-class, oral tyrosine kinase inhibitor (TKI) specifically designed...
FAPON to attend 41st Annual J.P. Morgan Healthcare Conference
SHENZHEN, China, Jan. 10, 2023 /PRNewswire/ -- FAPON, a leading life sciences company, today announces that its senior executive management will attend the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Jielun ZHU, CFO & CIO of FAPON, will be making a corporate presentation on January 11 about FAPON's insights into the industry and its strategies. This...
Clarivate Identifies Fifteen Potential Blockbuster Drugs in Annual Drugs to Watch Report
Report highlights personalized medicines ensuring greater efficacy for rare diseases and previously untreatable conditions Promising therapeutic developments for HIV, Parkinson's disease, Crohn's disease, alopecia, multiple myeloma and breast cancer on horizon LONDON, Jan. 10, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of...
Appointment of Dr. David John Jeans CBE as HistoIndex’s Non-Executive Chairman
SINGAPORE, Jan. 10, 2023 /PRNewswire/ -- The Board of Directors (the "Board") of HistoIndex (the "Company") would like to announce the following changes in appointments to the Board with effect from 6th December 2022: (1) Mr Sim Giok Lak's decision to step down as Non-Executive Chairman of the Board; and (2) The appointment of Dr. David John Jeans CBE,...
Futu partners Make-A-Wish fulfil unique wishes for four children living with critical illnesses
HONG KONG, Jan. 10, 2023 /PRNewswire/ -- People always welcome the new year full of anticipation. On entering a brand new year, we have good news of wishes coming true in the last two months of 2022, when Futu and Make-A-Wish successfully helped four "wish children" in Australia, the United States, Hong Kong...
Lydus Medical Announces FDA Clearance of Vesseal™, The Microvascular Anastomosis Aid Device for Small Arteries
RA'ANANA, Israel, Jan. 10, 2023 /PRNewswire/ -- Lydus Medical is pleased to announce that the Vesseal™ has received FDA clearance 510(k). The Vesseal™ is a microvascular anastomosis suture deployment system, for standardized omni-vessel anastomoses, enabling simple, fast, safe, and effective procedures. An anastomosis is one of the most complicated steps of microvascular surgery and...
AMPLIFY HEALTH ACCELERATES STRATEGY THROUGH THE ACQUISITION OF AiDA TECHNOLOGIES
Transaction complements and enhances Amplify Health's integrated health technology solutions stack and associated IP Adds new commercially proven capabilities and IP in artificial intelligence and machine learning SINGAPORE, Jan. 10, 2023 /PRNewswire/ -- Amplify Health, the pan-Asian integrated health technology solutions joint venture between AIA Group Limited and...
SK Inc. hosts “SK Bio Night” in San Francisco to expand global partnerships
SK to spark innovative ideas and identify new business opportunities by presenting its global strategy and growth roadmap to over 50 partners Newly appointed executives to lead SK's biopharmaceutical businesses to attend the event SK Inc. to promote the competitiveness of K-bio and provide insight into its remarkable achievements in...
SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at ‘SK Bio Night’
SK Inc.'s 1st SK Bio Night on the sidelines of J.P. Morgan Healthcare Conference offers a glimpse into the future of its global business in new drug, CDMO, biotech SK Biopharmaceuticals joins SK Inc.'s Bio Investment Center, SK pharmteco, or 'SK bio family,' for potential investment, partnerships SK Biopharmaceuticals CEO Donghoon Lee...
